Xtrackers MSCI Africa Top 50 Swap UCITS ETF 1C

INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the MSCI EFM AFRICA TOP 50 CAPPED TRN index (index) which is designed to reflect the performance of the listed shares of 50 companies from African emerging and frontier market countries, as classified by MSCI Inc. (MSCI). DESCRIPTION OF INDEX: The companies making up the index are large and medium sized companies. A company's weighting on the index depends on its relative size and only the 50 largest companies are included based on the combined value of a company's readily available shares as compared to other companies. The index is weighted and rebalanced in accordance with the MSCI 10/40 index Methodology (Methodology). The Methodology complies with legal requirements that the weight of a single issuer cannot exceed 10% of a fund's assets and the sum of the weights of all issuers representing more than 5% of the fund's assets cannot exceed 40%. The Methodology applies a buffer by providing that the shares of one company cannot exceed 9% of the index and the shares of all companies representing more than 4.5% of the index cannot together exceed 36% of the index. INDEX REBALANCING, CALCULATION AND ADMINISTRATION: The index is calculated on a total return net basis which means that all dividends and distributions are reinvested in the index after tax. The index is reviewed and rebalanced at least quarterly. INVESTMENT POLICY: To achieve the aim, the fund will enter into financial contracts (derivatives) with one or more swap counterparties to swap most subscription proceeds for the return on the index. FURTHER INFORMATION: Certain information (including the latest share prices of the fund, indicative net asset values, full disclosure on the composition of the fund's portfolio and information on the index constituents) are available on your local DWS website or at www.Xtrackers.com. Transaction costs and taxes, unexpected fund costs and market conditions such as volatility or liquidit

Synthetic replication - fully funded swap backed by collateral

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No